News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bayer HealthCare (BAY) to Present Data on Multiple Oncology Compounds at the European Cancer Congress (ECCO-ESMO-ESTRO) 2013


9/17/2013 11:12:51 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

WHIPPANY, N.J., Sept. 17, 2013 /PRNewswire/ -- Bayer HealthCare announced today that data from the company's oncology portfolio, including Nexavar® (sorafenib) tablets, Stivarga® (regorafenib) tablets and Xofigo® (radium Ra 223 dichloride) injection will be presented at the 2013 European Cancer Congress (ECCO/ESMO/ESTRO), September 28 – October 1, in Amsterdam, Netherlands.

Help employers find you! Check out all the jobs and post your resume.

Read at press release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES